Normal ESR, CRP and Platelet Count in Giant Cell Arteritis and Polymyalgia Rheumatica: A Diagnostic Conundrum
Abdullahi Elsheikh Mahgoub1, Sophia Tessema2, Rasha Nakhleh3
1Department of Internal Medicine, Michigan State University at Hurley Medical Center, Flint, MI, USA.
Insights
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) can present with normal inflammatory markers. Clinical suspicion and biopsy are crucial for diagnosing GCA and PMR, even with normal labs.
Area of Science:
- Rheumatology
- Internal Medicine
- Pathology
Background:
- Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are common rheumatological conditions in the elderly.
- These diseases are often associated with elevated inflammatory markers.
Purpose of the Study:
- To highlight the importance of clinical presentation in diagnosing GCA and PMR.
- To emphasize that normal inflammatory markers do not exclude GCA diagnosis.
Main Methods:
- Case report of a 61-year-old woman with symptoms of GCA and PMR.
- Diagnostic workup included laboratory tests and temporal artery biopsy.
- Treatment involved oral steroids and steroid-sparing agents.
Main Results:
- The patient presented with typical symptoms but normal inflammatory markers.
- Temporal artery biopsy confirmed GCA.
- The patient responded well to treatment, avoiding complications.
Conclusions:
- Normal inflammatory markers do not rule out GCA.
- Clinical presentation and pathological findings are critical for diagnosis.
- Early treatment initiation is vital for favorable outcomes in GCA and PMR.
Abstract:
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are both rheumatological diseases of the elderly with a strong association with each other and which rarely present with normal inflammatory markers. Here we present the case of a 61-year-old Caucasian woman who had typical symptoms of both diseases. At the time of presentation, her blood work showed normal inflammatory markers, but because of the high clinical suspicion for GCA, a temporal artery biopsy was done which was positive for giant cells and disruption of the internal elastic lamina. Our patient responded very well to treatment with oral steroids and steroid-sparing medication and was able to return to her normal life without experiencing any complications of the disease. By sharing our case, we aim to increase the awareness of medical personnel regarding the importance of focusing on the clinical presentation as well as the laboratory and pathological aspects of diagnosing GCA and PMR.
Learning Points:
Normal levels of inflammatory markers like C-reactive protein and the erythrocyte sedimentation rate do not rule out the diagnosis of giant cell arteritis (GCA).We aim to increase clinician recognition and awareness of other parameters, particularly the clinical presentation, that should be considered when diagnosing GCA or polymyalgia rheumatica.If the index of suspicion for the disease is high, it is crucial to start treatment as early as possible for better management and to avoid harmful complications.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...


